Research is being conducted on the use of TNF inhibitors during pregnancy in axial spondyloarthritis, with some studies examining their safety and effectiveness. The impact of these medications on pregnancy and the disease itself is being explored, including potential differences in how they affect men and women. The relationship between TNF inhibitor use and infection risk in children, as well as the overall management of axial spondyloarthritis in pregnant women, is also being investigated.